Cargando…
Assessment of the HScore as a predictor of disease outcome in patients with COVID-19
Severe coronavirus disease 2019 (COVID-19) accompanies hypercytokinemia, similar to secondary hemophagocytic lymphohistiocytosis (sHLH). We aimed to find if HScore could predict disease severity in COVID-19. HScore was calculated in hospitalized children and adult patients with a proven diagnosis of...
Autores principales: | Bordbar, Mohammadreza, Sanaei Dashti, Anahita, Amanati, Ali, Shorafa, Eslam, Mansoori, Yasaman, Dehghani, Seyed Javad, Molavi Vardanjani, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555714/ https://www.ncbi.nlm.nih.gov/pubmed/34715834 http://dx.doi.org/10.1186/s12890-021-01706-0 |
Ejemplares similares
-
Is the HScore useful in COVID-19?
por: Leverenz, David L, et al.
Publicado: (2020) -
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19
por: Loscocco, Giuseppe G.
Publicado: (2020) -
Utility of the HScore for Predicting COVID-19 Severity
por: Hannah, William, et al.
Publicado: (2022) -
Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura
por: Abdolkarimi, Babak, et al.
Publicado: (2022) -
Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis
por: Hossein Kazemi, Mohammad, et al.
Publicado: (2021)